British Journal of the Heart, 2 weeks ago
OPTIMIZING CROSSOVER FROM TICAGRELOR TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: THE CAPITAL OPTI-CROSS RANDOMIZED TRIAL - Journal of the American College of Cardiology, 2 months ago
TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL - Journal of the American College of Cardiology, 2 months ago
1 images for "clopidogrel"
Human medicines European public assessment report (EPAR): Iscover, clopidogrel, Revision: 31, Authorised
This is a summary of the European public assessment report (EPAR) for Iscover. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...European Medicines Agency, 1 month ago
The authors reply: We appreciate the interest in our study. In reply to Sipahi: in the clopidogrel-treated subgroup (6500 patients), the number of new cancers reported was 73 in the group that continued to receive thienopyridine and 55 in the ...New England Journal of Medicine, 1 month ago Optimal duration of dual antiplatelet therapy after drug eluting stent remains unclear British Medical Journal, 1 day ago Dual Perspectives on DAPT Orthopedics Today, 1 week ago Dual Antiplatelet Therapy After PCI With Drug Eluting Stents General Medicine eJournal, 2 weeks ago
You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 26 days for your content allowance to be renewed. Sign up for a free trial to ...FirstWord Pharma, 6 days ago Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients Diagnostic & Invasive Cardiology, 1 week ago Ticagrelor More Effective Than Clopidogrel in Low-Risk Patients Undergoing PCI: Presented at SCAI FirstWord Pharma, 2 weeks ago SCAI Release: Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel For Ad Hoc PCI Patients 5/7/2015 ClinicSpace, 2 weeks ago
Compared to Clopidogrel, Prasugrel Did Not Have a Higher Risk of Bleeding at 90 Days 12:05 ET from SCAI SAN DIEGO, May 8, 2015 /PRNewswire/ -- Prasugrel (Effient®) is more likely to be given to lower-risk heart disease patients undergoing ...PR Newswire, 2 weeks ago Prasugrel More Likely Candidate for Low-Risk Heart Disease Patients Diagnostic & Invasive Cardiology, 1 week ago
More from: Reuters, Minyanville...and 32 other sources
Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial ...PharmaceuticalProcessing, 1 month ago McCormack Pharma's Landmark Discovery could mean New Guidelines for use of Anti-Platelet Drug TickerTech.com, 1 month ago McCormack Pharma 's Landmark Discovery Could Mean New Guidelines For Use Of Anti-Platelet Drug BioSpace, 1 month ago
|Securities Technology Monitor, 1 month ago|
Six weeks of triple therapy with oral anticoagulation, aspirin and clopidogrel was not superior to a 6-month regimen for the primary outcome of death, MI, definite stent thrombosis, stroke or TIMI major bleeding at 9 months, according to data from ...Orthopedics Today, 3 weeks ago Duration of Triple Therapy After DES in Patients with Atrial Fibrillation New England Journal of Medicine, 2 hours ago Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial European Heart Journal, 6 days ago Trade-Off for Six Weeks Versus Six Months of Triple Tx Post Stent Physician's Briefing, 3 weeks ago
NEW YORK (Reuters Health) -- Three months of dual treatment with clopidogrel and aspirin after acute minor stroke or high-risk transient ischemic attack (TIA) had lasting benefit over 1 year in the CHANCE trial. The results of 1-year follow-up ...MedPage Today, 11 hours ago Dual antiplatelet therapy with clopidogrel and aspirin reduces stroke risk Cardiovascular Business, 2 weeks ago Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE): 1-Year Outcomes [Original Articles] Circulation: Cardiovascular Interventions, 2 weeks ago DAPT may reduce MACE, mortality in patients with symptomatic PAD Orthopedics Today, 4 weeks ago
DIFFERENTIAL IMPACT OF HIGH PLATELET REACTIVITY ON CLOPIDOGREL IN WOMEN AND MEN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH DES
on your WebpageAdd Widget >Get your members hooked!